Abstract:Aim: To study the methods of preparing the magnetic nano-microspheres of Fe(2)O(3) and As(2)O(3)/Fe(2)O(3) complexes and their therapeutic effects with magnetic fluid hyperthermia (MFH). Methods: Nanospheres were prepared by chemical co-precipitation and their shape and diameter were observed. Hemolysis, micronucleus, cell viability, and LD(50) along with other in vivo tests were performed to evaluate the Fe(2)O(3) microsphere biocompatibility. The inhibition ratio of tumors after Fe(2)O(3) and As(2)O(3)/Fe(2)O(3) injections combined with induced hyperthermia in xenograft human hepatocarcinoma was calculated. Results: Fe(2)O(3) and As(2)O(3)/Fe(2)O(3) particles were round with an average diameter of 20 nm and 100 nm as observed under transmission electron microscope. Upon exposure to an alternating magnetic field (AMF), the temperature of the suspension of magnetic particles increased to 41-51 degrees C, depending on different particle concentrations, and remained stable thereafter. Nanosized Fe(2)O(3) microspheres are a new kind of biomaterial without cytotoxic effects. The LD(50) of both Fe(2)O(3) and As(2)O(3)/Fe(2)O(3) in mice was higher than 5 g/kg. One to four weeks after Fe(2)O(3) and As(2)O(3)/Fe(2)O(3) complex injections into healthy pig livers, no significant differences were found in serum AST, ALT, BUN and Cr levels among the pigs of all groups (P > 0.05), and no obvious pathological alterations were observed. After exposure to alternating magnetic fields, the inhibition ratio of the tumors was significantly different from controls in the Fe(2)O(3) and As(2)O(3)/Fe(2)O(3) groups (68.74% and 82.79%, respectively; P < 0.01). Tumors of mice in treatment groups showed obvious necrosis, while normal tissues adjoining the tumor and internal organs did not. Conclusion: Fe(2)O(3) and As(2)O(3)/Fe(2)O(3) complexes exerted radiofrequency-induced hyperthermia and drug toxicity on tumors without any liver or kidney damage. Therefore, nanospheres are ideal carriers for tumor-targeted therapy.

Flame spray pyrolyzed carbon-encapsulated Au/Fe3O4 nanoaggregates enabled efficient photothermal therapy and magnetic hyperthermia of esophageal cancer cells

Tlyp-1-conjugated Core-Shell Nanoparticles, Fe3O4NPs@mSiO2, for Tumor-Targeted Drug Delivery

Fe3O4 Mesocrystals with Distinctive Magnetothermal and Nanoenzyme Activity Enabling Self-Reinforcing Synergistic Cancer Therapy.

Laser-triggered Aggregated Cubic Α-Fe2o3@au Nanocomposites for Magnetic Resonance Imaging and Photothermal/enhanced Radiation Synergistic Therapy.

Near-Infrared Laser Light Mediated Cancer Therapy By Photothermal Effect Of Fe3o4 Magnetic Nanoparticles

Nanosized As2O3/Fe2O3 complexes combined with magnetic fluid hyperthermia selectively target liver cancer cells

Facile Synthesis of Yolk-Shell Structured Fe3O4@C-Au Nanoparticles for Thermotherapic Application

Multifunctional Magnetic Nanoparticles for Synergistic Enhancement of Cancer Treatment by Combinatorial Radio Frequency Thermolysis and Drug Delivery

Photothermal effects and toxicity of Fe3O4 nanoparticles via near infrared laser irradiation for cancer therapy.

Facile Synthesis of Superparamagnetic Fe3o4@Au Nanoparticles for Photothermal Destruction of Cancer Cells

Shape-controlled Fabrication of Magnetite Silver Hybrid Nanoparticles with High Performance Magnetic Hyperthermia.

Multifunctional Mn 0.5 Zn 0.5 Fe 2 O 4 Nanoparticle/PPy-PEG Structures for Synergistic Photo-Magnetic Hyperthermia Applications

Multiwalled Carbon Nanotubes Decorated with Mn 0.5 Zn 0.5 Fe 2 O 4 Nanoparticles for Magneto-Photothermal Cancer Therapy

Ag@Fe3O4@C Nanoparticles for Multi-Modal Imaging-Guided Chemo-Photothermal Synergistic Targeting for Cancer Therapy.

Tumor microenvironment-responsive modular integrated nanocomposites for magnetically targeted and photothermal enhanced catalytic therapy

Magnetic/NIR-responsive Drug Carrier, Multicolor Cell Imaging, and Enhanced Photothermal Therapy of Gold Capped Magnetite-Fluorescent Carbon Hybrid Nanoparticles

Catalase-imprinted Fe3O4/Fe@fibrous SiO2/polydopamine nanoparticles: An integrated nanoplatform of magnetic targeting, magnetic resonance imaging, and dual-mode cancer therapy

MOF-derived Novel Porous Fe3O4@C Nanocomposites As Smart Nanomedical Platforms for Combined Cancer Therapy: Magnetic-Triggered Synergistic Hyperthermia and Chemotherapy

Fe3O4@PVP@DOX magnetic vortex hybrid nanostructures with magnetic-responsive heating and controlled drug delivery functions for precise medicine of cancers

A Novel Yolk–Shell Fe3O4@ Mesoporous Carbon Nanoparticle as an Effective Tumor-Targeting Nanocarrier for Improvement of Chemotherapy and Photothermal Therapy

CoFe2O4@MnFe2O4/polypyrrole Nanocomposites for in Vitro Photothermal/magnetothermal Combined Therapy